Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Twinrix Adult long-term antibody persistence and immune memory follow-up at years 16 to 20
2009-014853-33Phase 4Completed
- Sponsor
- GSK
- Start
- Nov 2009
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of hepatitis b vaccine recombinant, Hepatitis B vaccine and Hepatitis A virus vaccine in hepatitis A (HAV) and hepatitis B (HBV), sponsored by GSK. Primary endpoints: Antibody persistence against study vaccine antigens at each long-term follow-up visit and Immune response to challenge vaccination in subjects losing seroprotection or seropositivity. Started Nov 2009; status: completed.
02
Drugs
hepatitis b vaccine recombinantHepatitis B vaccineHepatitis A virus vaccine
03
Conditions
hepatitis A (HAV)hepatitis B (HBV)
Beyond the preview
Go deeper on 2009-014853-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014853-33.